In the media

Back to news lobby
Back to news lobby
In the Media 3 mins
June 09, 2022

AI-powered scope developer says new FDA clearance opens the door for telehematology

Scopio Labs today announced FDA 510(k) clearance for its X100HT, which features a new slide loader that automatically prepares samples and feeds them into the digital blood scanner for AI-powered analysis. The...
Link to full article

Scopio Labs today announced FDA 510(k) clearance for its X100HT, which features a new slide loader that automatically prepares samples and feeds them into the digital blood scanner for AI-powered analysis. The Tel Aviv-based digital microscope developer said the technology eliminates the need for manual microscopic examination when reviewing white and red blood cells and estimating platelet counts.

Back to news lobby
Latest press releases and coverage
Press Release
September 17, 2024

Beckman Coulter and Scopio Labs Add World’s First Digital Bone Marrow Imaging and Analysis to Long-Term Partnership

We are thrilled to announce the expansion of our long-term partnership with Beckman Coulter Diagnostics to include a global distribution agreement of Scopio’s Full-Field Bone Marrow Aspirate™ (FF-BMA)...
Read more
Press Release
July 25, 2024

Scopio Labs Secures $42 Million in Funding Led by Fortissimo Capital

New Funding to Accelerate Scopio Labs' Commercial Growth and Product Innovation in Full-Field Digital Cell Morphology
Read more
Press Release
April 17, 2024

Scopio Labs Receives Groundbreaking FDA Clearance for First-Ever Digital Bone Marrow Aspirate Application

The company’s 3rd FDA clearance accelerates the shift to AI-powered digital hematopathology, enhancing diagnostic speed and patient care.
Read more

Experience high resolution digital imaging and AI-driven full-field analysis

Book a demo